Granulosa cell tumour (patient information): Difference between revisions
Varun Kumar (talk | contribs) No edit summary |
m Robot: Changing Category:Disease state to Category:Disease |
||
Line 25: | Line 25: | ||
{{SIB}} | {{SIB}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Disease | [[Category:Disease]] | ||
[[Category:Gynecology]] | [[Category:Gynecology]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
Line 33: | Line 35: | ||
[[Category:Oncology patient information]] | [[Category:Oncology patient information]] | ||
[[Category:Overview complete]] | [[Category:Overview complete]] | ||
Revision as of 20:22, 9 December 2011
For the WikiDoc page for this topic, click here Template:DiseaseDisorder infobox
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Jinhui Wu, M.D.
Overview
Granulosa cell tumour is a type of stromal tumor of ovarian cancer. Stromal tumors start from connective tissue cells and produce hormones such as estrogen and progesterone. Granulosa cell tumour can occur at any age in a woman'life and the peak age is 50-55 years. Symptoms usually depend on the patient's age. Among postmenopausal patients, usual clinical presentation is abnormal uterine bleeding. Women in reproductive age group usually present with menometrorrhagia. Early development of breasts, pubic and axillary hair, stimulation and development of internal and external secondary sex organs, irregular uterine bleeding (Isosexual-pseudoprecocity) may be seen among young girls with granulosa cell tumor. Treatment include surgery, radiation therapy, chemotherapy and hormone therapy.
For more information, see: Ovarian cancer